Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

Mr. Bo  Shen

President, Chief Financial Officer, Head of the Accounting Department & Executive Director

Dr. Shunjiang  Yu

Chief Medical Officer

Ying  Ke

Director & General Manager of R&D Management Center

Mr. Qiuhua  Yang

Executive Chairman

Mr. Ming  Dong

Executive Director

Ms. Pui Kiu  Wong

Joint Company Secretary

Mr. Tao  Zhong

Vice President, Board Secretary & Joint Company Secretary

Mr. Yongzhong  Li

Vice President & Executive Director

Mr. Dongming  Li

Vice President

Ms. Shuai  Shao

Pavadinimas	Rinkos kapitalizacija
Itonis, Inc.	0M
Medlive Technology Co., Ltd.	0M
Patterson Companies, Inc.	0M
MediPal Holdings Corporation	0M
Medios AG	0M
Uniphar plc	0M
PT Enseval Putera Megatrading Tbk.	0M
Synergy CHC Corp.	0M
EBOS Group Limited	0M
Yamashita Health Care Holdings,Inc.	0M

Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd Konkurentų sąrašas

Pagrindiniai konkurentai